English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 857894 Online Users : 685
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
Institute of Molecular and Genomic Medicine
Institute of Biotechnology and Pharmaceutical Research
Institute of Biomedical Engineering and Nanomedicine
Immunology Research Center
Center for Neuropsychiatric Research
Institute of Cellular and Systems Medicine
National Institute of Infectious Diseases and Vaccinology
Institute of Population Health Sciences
National Institute of Cancer Research
National Institute of Environmental Health Sciences
National Mosquito-Borne Diseases Control Research Center
National Center for Geriatrics and Welfare Research
Forum
Center of Biomedical Resource
NHRI Graduate Student Program
Core Instrument Center
Pathology Core Laboratory
Laboratory Animal Center
Administrative Units
圖書館
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
NHRI
>
Items for Author
Loading...
Category
Loading community tree, please wait....
Year
Loading year class tree, please wait....
Items for Author "Tabernero, J"
Return to Browse by Author
Showing 9 items.
Collection
Date
Title
Relation
Bitstream
[陳立宗] 會議論文/會議摘要
2011-02
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma
-
[陳立宗] 期刊論文
2024-06-17
Plain language summary of the FOENIX-CCA2 study: Futibatinib for people with advanced bile duct cancer
-
[陳立宗] 期刊論文
2013-06-21
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
-
[陳立宗] 期刊論文
2018-01
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
-
[陳立宗] 期刊論文
2019-01
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
-
[陳立宗] 期刊論文
2019-01
Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
-
[陳立宗] 期刊論文
2020-03
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
-
[陳立宗] 期刊論文
2020-07
JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
-
[陳立宗] 期刊論文
2023-01-19
Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma
-
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback